These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23745249)

  • 21. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.
    Lee YN; Hwang HS; Kim MC; Lee YT; Lee JS; Moore ML; Kang SM
    Antiviral Res; 2015 Mar; 115():1-8. PubMed ID: 25513755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.
    de Waal L; Süzer Y; Wyatt LS; Sintnicolaas K; Sutter G; Moss B; Osterhaus AD; de Swart RL
    Viral Immunol; 2006; 19(4):669-78. PubMed ID: 17201662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural polymorphisms and resistance-associated mutations in the fusion protein of respiratory syncytial virus (RSV): effects on RSV susceptibility to palivizumab.
    Zhu Q; Patel NK; McAuliffe JM; Zhu W; Wachter L; McCarthy MP; Suzich JA
    J Infect Dis; 2012 Feb; 205(4):635-8. PubMed ID: 22184728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory syncytial virus fusion glycoprotein: further characterization of a major epitope involved in virus neutralization.
    Trudel M; Nadon F; Séguin C; Payment P; Talbot PJ
    Can J Microbiol; 1987 Oct; 33(10):933-8. PubMed ID: 2446731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
    Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
    J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing epitopes of RSV and palivizumab resistance in Japan.
    Hashimoto K; Hosoya M
    Fukushima J Med Sci; 2017 Dec; 63(3):127-134. PubMed ID: 28867684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
    da Silva J; Hughes AL
    Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
    Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
    Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Nieuwkoop NJ; Spronken MI; van de Vijver DA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2016 Jan; 90(2):1009-22. PubMed ID: 26537686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.
    Bukreyev A; Serra ME; Laham FR; Melendi GA; Kleeberger SR; Collins PL; Polack FP
    J Virol; 2006 Jun; 80(12):5854-61. PubMed ID: 16731924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variability of the fusion protein and circulation patterns of genotypes of the respiratory syncytial virus.
    Kim YK; Choi EH; Lee HJ
    J Med Virol; 2007 Jun; 79(6):820-8. PubMed ID: 17457915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion of DsbA to the N-terminus of CTL chimeric epitope, F/M2:81-95, of respiratory syncytial virus prolongs protein- and virus-specific CTL responses in Balb/c mice.
    Fan CF; Zeng RH; Sun CY; Mei XG; Wang YF; Liu Y
    Vaccine; 2005 Apr; 23(22):2869-75. PubMed ID: 15780735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.
    Coelingh KV; Winter CC
    J Virol; 1990 Mar; 64(3):1329-34. PubMed ID: 1689394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
    Marsh R; Connor A; Gias E; Toms GL
    J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a linear epitope on the fusion glycoprotein of respiratory syncytial virus.
    Scopes GE; Watt PJ; Lambden PR
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():53-9. PubMed ID: 1689370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.